期刊文献+

甘草次酸在人细胞色素CYP450中体外代谢研究(英文) 被引量:17

In vitro metabolism of glycyrrhetic acid by human cytochrome P450
原文传递
导出
摘要 甘草根是中医临床常用解毒草药,其活性成分甘草次酸主要是通过肝脏代谢。本文研究了人肝微粒体以及人源性CYP450s对甘草次酸的体外代谢影响,以及甘草次酸对几种CYP450酶活性的影响。实验结果表明,甘草次酸体外主要代谢酶为CYP3A4。体外药代动力学参数Km,Vmax和CLint分别为18.6μmol.L-1,4.4 nmol.mg-1(protein).min-1和0.237 mL.mg-1(protein).min-1。体外抑制试验显示,50μmol.L-1甘草次酸可以抑制CYP2C19、CYP2C9、CYP3A4酶的活性,其抑制率可高达50%以上。 Licorice root has been frequently used as antitode in traditional Chinese medicine.As the main active component of Licorice root,glycyrrhetic acid(GA) is mainly metabolized in liver.This study was designed to investigate the in vitro metabolism of GA by human liver microsomes(HLM) and human recombinant cytochrome P450(CYP) isoforms.The results indicated that GA was metabolized mainly by CYP3A4.The Km,Vmax and CLint of GA in HLM were 18.6 μmol·L-1,4.4 nmol·mg-1(protein)·min-1 and 0.237 mL·mg-1(protein)·min-1,respectively.At concentration up to 50 μmol·L-1,GA inhibited CYP2C19,CYP2C9 and CYP3A4 enzyme activities with the inhibitory potencies up to 50%.
出处 《药学学报》 CAS CSCD 北大核心 2011年第1期81-87,共7页 Acta Pharmaceutica Sinica
基金 supported by National Natural Science Foundation of China (No.30630075) the Grant 020092325 of the Key Technology R&D Program of China Hubei Provincial Science&Technology Department
关键词 甘草次酸 代谢 人肝微粒体 细胞色素P450 glycyrrhetic acid metabolism human liver microsome cytochrome P450
  • 相关文献

参考文献3

二级参考文献99

  • 1朱立勤,娄建石.细胞色素P450与药物代谢的研究现状[J].中国临床药理学与治疗学,2004,9(10):1081-1086. 被引量:51
  • 2金建军,夏德全.甘草甜素药代动力学的研究进展[J].国外医学(中医中药分册),1994,16(1):13-15. 被引量:11
  • 3李丽萍,蒋惠娣.肠道菌群对菊花提取物的代谢作用[J].中草药,2006,37(7):1001-1004. 被引量:19
  • 4杨锦南,朱明.甘草次酸及其衍生物药理作用研究进展[J].中国药理学通报,1997,13(2):110-114. 被引量:36
  • 5Guengerich FE Cytochromes P450, drugs, and diseases [J]. Mol Interv, 2003, 3: 194-204.
  • 6Ripp SL, Mills JB, Fahmi OA, et al. Use of immortalized human hepatocytes to predict the magnitude of clinical drug- drug interactions caused by CYP3A4 induction [J]. Drug Metab Dispos, 2006, 34:1742-1748.
  • 7Fowler S, Zhang H. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions [J]. AAPS J, 2008, 10: 410-424.
  • 8Obach RS, Walsky RL, Venkatakrishnan K, et al. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions [J]. J Pharmacol Exp Ther, 2006, 316: 336-348.
  • 9Ohno Y, Hisaka A, Ueno M, et al. General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information [J]. Clin Pharmacokinet, 2008, 47: 669-680.
  • 10Brown HS, Ito K, Galetin A, et al. Prediction of in vivo drugdrug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant [J]. Br J Clin Pharmacol, 2005, 60: 508-518.

共引文献35

同被引文献173

引证文献17

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部